The average one-year price target for Denali Therapeutics Inc. is $ The forecasts range from a low of $ to a high of $ Earnings for Denali Therapeutics are expected to decrease in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/E. Exchange. NASDAQ-GS ; Sector. Health Care ; Industry. Biotechnology: Biological Products (No Diagnostic Substances) ; 1 Year Target. $ ; Today's High/Low. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Analyst Price Targets ; ; Average ; Current ; High.
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing. Denali Therapeutics Inc. ; Volume, M ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Denali Therapeutics stock price target cut to $41 from $60 at Stifel Nicolaus. Mar. 2, at a.m. ET by Tomi Kilgore. Discover Denali Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. DNLI Stock Overview · Revenue is forecast to grow % per year · Currently unprofitable and not forecast to become profitable over the next 3 years. Get Denali Therapeutics Inc (DNLI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. What was Denali Therapeutics's price range in the past 12 months? Denali Therapeutics lowest stock price was $ and its highest was $ in the past Denali Therapeutics has return on total asset (ROA) of () % which means that it has lost $ on every $ spent on assets. This is way below average. Denali Therapeutics Stock Forecast, DNLI stock price prediction. Price target in 14 days: USD. The best long-term & short-term Denali Therapeutics. The average price target is $ with a high estimate of $90 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. The current price of DNLI is USD — it has increased by % in the past 24 hours. Watch Denali Therapeutics Inc. stock price performance more closely on.
The Denali Therapeutics stock prediction for is currently $ , assuming that Denali Therapeutics shares will continue growing at the average yearly. Find the latest Denali Therapeutics Inc. (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. Denali Therapeutics price target lowered to $30 from $31 at Wedbush by TipRanks 1-year stock price forecast. DNLI Competitors. Facts Insights Learn. Denali Therapeutics (DNLI) stock price prediction is USD. The Denali Therapeutics stock forecast is USD for August According to analysts, DNLI price target is USD with a max estimate of USD and a min estimate of USD. 23 analysts offering month price forecasts for Denali Therapeutics Inc (DNLI) have a share price target of $ This median of share price forecast. On average, Wall Street analysts predict that Denali Therapeutics's share price could reach $ by Aug 15, The average Denali Therapeutics stock price. Earnings for Denali Therapeutics are expected to decrease in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/E. Stock Price Forecast. The 9 analysts with month price forecasts for Denali Therapeutics stock have an average target of , with a low estimate of 22 and.
Stock price target for Denali Therapeutics Inc. DNLI are 22 on downside and on. Tomorrow Target 1, Tomorrow Target 2, Tomorrow Target 3. The 35 analysts offering price forecasts for Denali Therapeutics have a median target of , with a high estimate of and a low estimate of Based on short-term price targets offered by 15 analysts, the average price target for Denali Therapeutics Inc. comes to $ The forecasts range from a low. According to 9 analysts, the average rating for DNLI stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the. DNLI - Denali Therapeutics - Stock Forecast DNLI is currently covered by 10 analysts with an average price target of $ This is a potential upside of.
Denali Therapeutics Inc Stock Price Forecast, "DNLI" Predictons for How much is Denali Therapeutics's stock price per share? (NASDAQ: DNLI) Denali Therapeutics stock price per share is $ today (as of Aug 21, ). · What is. What is the forecast, or price target, for Denali Therapeutics (DNLI) stock? A. Denali Therapeutics has a consensus price target of $ Q. What is the. Discover all the factors affecting Denali Therapeutics's share price. DNLI is currently rated as a Neutral | Stockopedia. View the latest Denali Therapeutics Inc. (DNLI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Denali Therapeutics Inc's average analyst rating is Strong Buy. Stock Target Advisor's own stock analysis of Denali Therapeutics Inc is Neutral, which is based.